NFL Biosciences (France) Performance
| ALNFL Stock | 1.85 0.05 2.78% |
The company secures a Beta (Market Risk) of -0.39, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning NFL Biosciences are expected to decrease at a much lower rate. During the bear market, NFL Biosciences is likely to outperform the market. At this point, NFL Biosciences SAS has a negative expected return of -0.13%. Please make sure to verify NFL Biosciences' total risk alpha, expected short fall, market facilitation index, as well as the relationship between the value at risk and daily balance of power , to decide if NFL Biosciences SAS performance from the past will be repeated in the future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days NFL Biosciences SAS has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's basic indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors. ...more
NFL |
NFL Biosciences Relative Risk vs. Return Landscape
If you would invest 210.00 in NFL Biosciences SAS on September 30, 2024 and sell it today you would lose (25.00) from holding NFL Biosciences SAS or give up 11.9% of portfolio value over 90 days. NFL Biosciences SAS is generating negative expected returns and assumes 3.7008% volatility on return distribution over the 90 days horizon. Simply put, 32% of stocks are less volatile than NFL, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
NFL Biosciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for NFL Biosciences' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as NFL Biosciences SAS, and traders can use it to determine the average amount a NFL Biosciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0357
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ALNFL |
Estimated Market Risk
| 3.7 actual daily | 32 68% of assets are more volatile |
Expected Return
| -0.13 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average NFL Biosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NFL Biosciences by adding NFL Biosciences to a well-diversified portfolio.
Things to note about NFL Biosciences SAS performance evaluation
Checking the ongoing alerts about NFL Biosciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for NFL Biosciences SAS help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| NFL Biosciences SAS generated a negative expected return over the last 90 days | |
| NFL Biosciences SAS may become a speculative penny stock | |
| NFL Biosciences SAS has high historical volatility and very poor performance |
- Analyzing NFL Biosciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether NFL Biosciences' stock is overvalued or undervalued compared to its peers.
- Examining NFL Biosciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating NFL Biosciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of NFL Biosciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of NFL Biosciences' stock. These opinions can provide insight into NFL Biosciences' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for NFL Stock Analysis
When running NFL Biosciences' price analysis, check to measure NFL Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NFL Biosciences is operating at the current time. Most of NFL Biosciences' value examination focuses on studying past and present price action to predict the probability of NFL Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NFL Biosciences' price. Additionally, you may evaluate how the addition of NFL Biosciences to your portfolios can decrease your overall portfolio volatility.